หน้าแรก
ค้นหา
Dr. Michael J. Overman on Immunotherapy in Colorectal Cancer
No description available
แสดงข้อมูลเพิ่มเติม 1
Dr. Michael J. Overman on Immunotherapy in Colorectal Cancer
Dr. Overman on Second-Line Therapy Options for Colorectal Cancer
Dr. Overman on Next Steps With Immunotherapy in mCRC
Dr. Overman on Unmet Needs With Immunotherapy in mCRC
The Role of Immunotherapy in Colorectal Cancer
Dr. Overman Discusses Updated Findings of CheckMate-142 in Patients With MSI-H mCRC
Immunotherapy in Colorectal Cancer
Dr. Overman on the Impact of Nivolumab in mCRC
Dr. Overman on Nivolumab and Ipilimumab in Patients With MSI-H CRC
Dr. Overman on Implications of Tumor Location Data for Patients With mCRC
Dr. Overman on Potential Applications of ctDNA in Colorectal Cancer
Dr. Overman Discusses ReDOS Study in mCRC
Updated Results for Nivolumab in MSI-H Colorectal Cancer
Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part Series
Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part Series
Interdisciplinary Approaches to Personalizing Immunotherapy in Metastatic CRC
Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part Series
Dr. Venook on Immunotherapy Potential in Colorectal Cancer
Dr. Overman on Tailoring Approaches to Molecular Subsets in mCRC
Dr. Larson on Immunotherapy for Colorectal Cancer
